| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Active Surveillance Versus Radical Prostatectomy in Favorable-risk Localized Prostate Cancer
|
Thomsen, Frederik B.
|
|
2019
|
17 |
4 |
p. e814-e821
|
artikel
|
| 2 |
Body Mass Index and Outcomes in Germ-Cell Tumors
|
McGregor, Bradley A.
|
|
2019
|
17 |
4 |
p. 283-290
|
artikel
|
| 3 |
Cabozantinib in Renal Cell Carcinoma With Brain Metastases: Safety and Efficacy in a Real-World Population
|
Peverelli, Giorgia
|
|
2019
|
17 |
4 |
p. 291-298
|
artikel
|
| 4 |
Can We Improve the Preoperative Prediction of Prostate Cancer Recurrence With Multiparametric MRI?
|
Capogrosso, Paolo
|
|
2019
|
17 |
4 |
p. e745-e750
|
artikel
|
| 5 |
Comparison of Different Treatment Modalities Outcomes in Clinically Node-positive Bladder Cancer: Analysis of a Population-based Cancer Registry
|
Staník, Michal
|
|
2019
|
17 |
4 |
p. e759-e767
|
artikel
|
| 6 |
Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma: A Population-Based Comparison Between Surveillance and Active Treatment After Orchiectomy
|
Mistretta, Francesco A.
|
|
2019
|
17 |
4 |
p. e793-e801
|
artikel
|
| 7 |
Cost Analysis of Noninvasive Blood-Based MicroRNA Testing Versus CT Scans for Follow-up in Patients With Testicular Germ-Cell Tumors
|
Charytonowicz, Daniel
|
|
2019
|
17 |
4 |
p. e733-e744
|
artikel
|
| 8 |
DNA Damage Response Pathway Alteration in Locally Advanced Clear-Cell Renal-Cell Carcinoma Is Associated With a Poor Outcome
|
Na, Joon Chae
|
|
2019
|
17 |
4 |
p. 299-305.e1
|
artikel
|
| 9 |
Editorial Board
|
|
|
2019
|
17 |
4 |
p. IFC
|
artikel
|
| 10 |
Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression
|
Di Maida, Fabrizio
|
|
2019
|
17 |
4 |
p. e751-e758
|
artikel
|
| 11 |
Folic Acid Reduces Mucositis in Metastatic Renal Cell Carcinoma Patients: A Retrospective Study
|
Fristrup, Niels
|
|
2019
|
17 |
4 |
p. 254-259
|
artikel
|
| 12 |
Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium
|
Paller, Channing J.
|
|
2019
|
17 |
4 |
p. 275-282.e1
|
artikel
|
| 13 |
Impact of Anatomic Location of Bone Metastases on Prognosis in Metastatic Castration-Resistant Prostate Cancer
|
Roth, Alison R.
|
|
2019
|
17 |
4 |
p. 306-314
|
artikel
|
| 14 |
Interobserver Agreement of the Estimated Contact Surface Area System for Renal Masses
|
Haifler, Miki
|
|
2019
|
17 |
4 |
p. e802-e805
|
artikel
|
| 15 |
Is There a Benefit of Addition Docetaxel, Abiraterone, Celecoxib, or Zoledronic Acid in Initial Treatments for Patients Older Than 70 Years With Hormone-sensitive Advanced Prostate Cancer? A Meta-analysis
|
Landre, Thierry
|
|
2019
|
17 |
4 |
p. e806-e813
|
artikel
|
| 16 |
Laparoscopic Approach in Management of Renal Cell Carcinoma During Pregnancy: State of the Art
|
Dell’Atti, Lucio
|
|
2019
|
17 |
4 |
p. e822-e830
|
artikel
|
| 17 |
Moreau Strain Bacillus Calmette-Guérin Low Versus Standard Dose in the Treatment of High-Grade T1 Bladder Cancer: A Retrospective Observational Cohort Study
|
Carneiro, Bruno D.B.
|
|
2019
|
17 |
4 |
p. e779-e783
|
artikel
|
| 18 |
Mucinous Tubular and Spindle-Cell Carcinoma of the Kidney: Clinical Features, Genomic Profiles, and Treatment Outcomes
|
Ged, Yasser
|
|
2019
|
17 |
4 |
p. 268-274.e1
|
artikel
|
| 19 |
Prognostic Significance of Sites of Visceral Metastatic Disease in Prostate Cancer: A Population-based Study of 12,180 Patients
|
Budnik, Justin
|
|
2019
|
17 |
4 |
p. 260-267
|
artikel
|
| 20 |
Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study
|
Cattrini, Carlo
|
|
2019
|
17 |
4 |
p. e724-e732
|
artikel
|
| 21 |
Prostate Cancer Incidence and Mortality in Relationship to Family History of Prostate Cancer; Findings From The PLCO Trial
|
Abdel-Rahman, Omar
|
|
2019
|
17 |
4 |
p. e837-e844
|
artikel
|
| 22 |
Quality Control Indicators for Transurethral Resection of Non–Muscle-Invasive Bladder Cancer
|
Akand, Murat
|
|
2019
|
17 |
4 |
p. e784-e792
|
artikel
|
| 23 |
Randomized Phase II Trial of Abiraterone Alone or With Dasatinib in Men With Metastatic Castration-resistant Prostate Cancer (mCRPC)
|
Dorff, Tanya B.
|
|
2019
|
17 |
4 |
p. 241-247.e1
|
artikel
|
| 24 |
Rapid Deep Responses With Nivolumab Plus Ipilimumab in Papillary Renal Cell Carcinoma With Sarcomatoid Dedifferentiation
|
Schvartsman, Gustavo
|
|
2019
|
17 |
4 |
p. 315-318
|
artikel
|
| 25 |
Safety and Efficacy of Nivolumab in Patients With Metastatic Renal Cell Carcinoma and End-stage Renal Disease at 2 Centers
|
Tachibana, Hidekazu
|
|
2019
|
17 |
4 |
p. e772-e778
|
artikel
|
| 26 |
Salvage Prostate Cryoablation for the Management of Local Recurrence After Primary Cryotherapy: A Retrospective Analysis of Functional and Intermediate-Term Oncological Outcomes Associated With a Second Therapeutic Freeze
|
Aminsharifi, Alireza
|
|
2019
|
17 |
4 |
p. e831-e836
|
artikel
|
| 27 |
Serum Proteomics on the Basis of Discovery of Predictive Biomarkers of Response to Androgen Deprivation Therapy in Advanced Prostate Cancer
|
Kohli, Manish
|
|
2019
|
17 |
4 |
p. 248-253.e7
|
artikel
|
| 28 |
Stereotactic Ablative Radiotherapy (SAbR) in the Setting of Metastatic Nonseminomatous Germ Cell Tumor of Testis
|
Satyanarayan, Arthi
|
|
2019
|
17 |
4 |
p. e768-e771
|
artikel
|
| 29 |
Successful Treatment of Metastatic Adult Wilms Tumor With Anti-BRAF Treatment: A Case Report and a Brief Review of the Literature
|
de Vries-Brilland, Manon
|
|
2019
|
17 |
4 |
p. e721-e723
|
artikel
|
| 30 |
Table of contents
|
|
|
2019
|
17 |
4 |
p. A5-A9
|
artikel
|
Tijdschrift beschrijving